主な発表論文

・Aihara T, Fujiwara Y, Ooka M, Sakita I, Tamaki Y, Monden M.   Mammaglobin B as a novel marker for detection of breast cancer micrometastases in axillary lymph nodes by reverse transcription-polymerase chain reaction. (Breast Cancer Res Treat 1999;58:137-40.) ・Aihara T, Kim Y, Takatsuka Y.   Phase II study of weekly docetaxel in patients with metastatic breast cancer. (Ann Oncol 2002;13(2):286-92.) ・Aihara T, Takatsuka Y, Itoh K, Sasaki Y, Katsumata N, Watanabe T, Noguchi S, Horikoshi N, Tabei T, Sonoo H, Hiraki S, Inaji H.   Phase II study of concurrent administration of doxorubicin and docetaxel as first-line chemotherapy for metastatic breast cancer. (Oncology. 2003;64(2):124-30.) ・Aihara T, Takatsuka Y.   Dye-guided sentinel node biopsy revisited; validation and observational study from a single institute. (Breast Cancer. 2003;10:254-9. ) ・Aihara T, Munakata S, Morino H, Takatsuka Y.   Touch imprint cytology and immunohistochemistry for the assessment of sentinel lymph nodes in patients with breast cancer. (Eur J Surg Oncol. 2003 ;29(10):845-8.) ・Aihara T, Munakata S, Morino H, Takatsuka Y.   Feasibility of sentinel node biopsy for breast cancer after neoadjuvant endocrine therapy: a pilot study. (J Surg Oncol. 2004 ;85(2):77-81.) ・Aihara T, Munakata S, Morino H, Takatsuka Y.   Comparison of frozen section and touch imprint cytology for evaluation of sentinel lymph node metastasis in breast cancer. (Ann Surg Oncol, 2004 ;11(8):747-50.)
・相原智彦   「産褥期の腫瘍性疾患への対応」 (ペリネイタルケア 2005年8月号)
・相原智彦、高塚雄一   「乳癌の術前化学療法」          >> 詳細 (医薬の門 2006年9月)